The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-fusion-devices-market-101689

Growing Adoption of Surgical Robots for Spinal Injuries to Prove Favorable for the Market

There is an increasing demand for minimally invasive surgical procedures, prompting many hospitals to adopt robots for performing surgical procedures for the spinal treatments. As a result, manufacturers are now increasingly engaging in developing novel robotic technologies to aid surgeons perform tricky spinal cord surgeries with greater ease and accuracy. Thus, emergence of robotics in healthcare is, therefore, expected to shape the spinal fusion devices market trends during the forecast period.

North America to Hold a Commanding Position; Europe to Display Healthy Growth Pattern

With a revenue generation of USD 3.02 billion in 2018, North America is poised to dominate the spinal fusion devices market share. This will be a result of increasing incidence of chronic pain in the U.S. and a ready adoption of advanced spinal fusion implant devices. In Europe, a rising demand for 3D printed medical devices and a growing proclivity towards minimally invasive procedures will drive the market for spine fusion implants in the continent

The global point-of-care (POC) diagnostics market size is expected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. The growing acceptance of POC testing kits in the treatment of acute and chronic diseases will spur ruminative opportunities for the global market, states Fortune Business Insights, in a report, titled “Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-Testing), and Regional Forecast, 2020-2027.” The market size stood at USD 18.45 billion in 2019.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

The report on thepoint-of-care (POC) diagnostics market Depicts:

• Prominent understandings of the market
• Swot Analysis of the regions
• Latest market trends and developments
• Stellar insights into the competitive landscape
• Prime data about regional players
• Coronavirus impact

Market Driver:

Introduction ofAdvanced Testing Kits to Enhance Market Scope

 The growing cases of diseases such as diabetes, infectious disease, HIV, and others have urged pharmaceutical companies to introduce innovative testing kits, which, in turn, will enable the growth of the market. For instance, in June 2019, Abbott announced the release of the Afinion HbA1c Dx assay. This assay is the first of its kind point-of-care test that has been approved by the U.S FDA for the diagnosis of diabetes. Moreover, in February 2019, DiabetOmics introduced the point-of-care test Lumella for the accurate diagnosis of preeclampsia in pregnant women. Hence, the continuous and persistent efforts of major companies for the development of advanced POC kits will simultaneously encourage the healthy growth of the market in the forthcoming years.

The global alopecia treatment market size isestimated to reach USD 13,454.16 million by 2027 on account of the increasing number of hair loss cases in people irrespective of gender and age.Alopecia areata is a medical condition that results in hair loss in patches for both males and females. The immune system of the body attacks the hair follicles and ultimately results in loss of hair on the scalp, eyebrows, eyelashes, and face. According to a recent report by Fortune Business Insights titled, “Alopecia Treatment Market Size, Share & Industry Analysis, By Route of Administration (Topical, Injectable, Oral), By Gender Type (Male, Female), By Age Group (Below 18 years, 18 – 34 Years, 35 – 49 Years, Above 50 Years), By End User (Hospitals and Physician Offices, Dermatology Clinics, Others) and Regional Forecast, 2020-2027,” the market value stood at USD 8,894.78 million in 2019 and is anticipated to rise at a CAGR of 5.2% between 2020 to 2027.

for more information: https://www.fortunebusinessinsights.com/alopecia-treatment-market-102822

List of Alopecia Treatment Market Manufacturers include:

• Follicum AB
• Concert Pharmaceuticals Inc.
• Daiichi Sankyo
• Johnson & Johnson
• Merck & Co., Inc.,
• Aclaris Therapeutics, Inc.
• Fagron
• Sun Pharmaceutical Industries Ltd.
• Cipla Inc.
• GlaxoSmithKline plc.
• Other Players

Massive Investments on Clinicals will Augment Growth

Various factors are responsible for the alopecia treatment of market growth. These include increasing adoption of a sedentary lifestyle, binge eating habits, cigarette consumption, and others that ultimately weaken the immune system. In addition to this, there is heavy investment in hair transplantation systems, and thiswill also add impetus to the market in the forecast period.

The Middle East and Africa Market to Witness Remarkable Growth with Rising Medical Tourism

Asia Pacific earned a revenue of USD 3,114.14 million in 2019 and emerged dominant. This is attributed to the rising prevalence of alopecia in the region. Various studies state that the increasing population and adoption of a sedentary lifestyle will add impetus to the market in this region. This, coupled with the rising consumption of tobacco may lead to weaker immune systems and increase stress level, thereby leading to hairfall. Additionally, the aggressive regional penetration and the increasing number of hair treatment companies setting up bases will further help this region continue earning the largest alopecia treatment market share in the coming years.

The global “Biomaterials Market” is set to gain impetus from the increasing usage of a wide variety of biomaterials because of their clinical efficiencies. They also provide several benefits in wound healing applications. Fortune Business Insights™ published this information in a recent report, titled, “Biomaterials Market and Industry Analysis, By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers, and Natural Biomaterials), By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Urology, Gastroenterology, and Others), and Regional Forecast, 2020-2027.”

Click here to get the short-term and long-term impact of COVID-19 on this Biomaterials Market. Please visit: https://www.fortunebusinessinsights.com/biomaterials-market-102770

The report further mentions that the biomaterials market size was USD 110.0 billion in 2019 and is projected to reach USD 245.6 billion by 2027, thereby exhibiting a CAGR of 12.2% during the forecast period from 2020–2027.

Segment-

Metallic Biomaterials Segment to Lead Backed by Usage in Several Medical Applications

In terms of material, the metallic biomaterials segment held 30.1% market share in 2019 and is likely to lead throughout the forthcoming period. They are specially developed to deliver internal support to biological tissues. They are mainly used for orthopedic fixations, stents, dental implants, and joint replacements. In addition to that, they possess various mechanical properties, such as swiftness. These make them best suited for load-bearing implants.

The global cosmetic surgery market is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report, titled, “Cosmetic Surgery Market Size, Share & Industry Analysis, By Type (Surgical Procedures, and Non-Surgical Procedures), By Gender (Males, and Females), By End User (Spas & Cosmetic Surgery Centers, and Hospitals & Specialty Clinics), and Regional Forecast, 2019-2026.” The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/cosmetic-surgery-market-102628

What Does This Report Contain?

• Elaborate information about the factors that would accelerate the market growth in the coming years.
• Comprehensive data about all those factors that are set to pose as growth barriers.
• In-depth analysis of the cosmetic surgery market trends, challenges, and opportunities.
• A thorough analysis of the competitive landscape and profiles of all the vendors.

Drivers & Restraints-

Rising Emphasis on Reduced Post-surgical Interventions to Propel Growth

The market consists of several prominent companies that are presently focusing on capitalizing their market share by delivering new instruments and products to the masses. Besides, the demand for unique products with reduced post-surgical interventions and adverse effects is aiding these companies in investing huge sums in research and development activities.

Furthermore, patients and healthcare providers are nowadays looking for state-of-the-art products. Coupled with this, the rising emphasis on removing the harmful effects of implants and other similar cosmetic procedures would contribute to the aesthetic surgery market growth in the near future. However, the emergence of non-licensed facilities worldwide may hamper the market growth.

The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled “Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026,” the market was worth USD 6.56 billion in 2018 and will exhibit a CAGR of 5.4% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/cataract-surgical-devices-market-101957

The increasing prevalence of cataract surgeries has opened up a huge potential for the growth of the companies operating in the market. Recent technological advances in these devices have allowed for improved surgical procedures. The improved efficacies of these devices has in turn led to an increased adoption of cataract surgeries. In addition to this, the favourable health reimbursement policies have contributed to the growing adoption of cataract surgeries and subsequent rise in the demand for cataract surgical devices. The growing demand will have a direct impact on the growth of the market in the coming years.

The report provides an in-depth analysis of the global cataract surgical devices market. It highlights the latest product launches and recent innovations in the market and states their impact on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years. Forecast values have been provided for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals.

The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-fusion-devices-market-101689

According to a new report published by Fortune Business Insights, titled “Spinal Fusion Devices Market Size, Share & Industry Analysis, By Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026”, the market value stood at USD 6.37 billion in 2018. Within the report is also contained an exhaustive evaluation and analysis of the drivers, restraints, and other dynamics that will influence the market in the forecast period. Besides this, the report also provides a macroscopic overview of the general industry trends that will enable businesses to align their strategies with the needs of the market.

Wide Availability of Opportunities to Innovate to Stimulate Competition

The spinal fusion devices market is set to receive a new influx of energy as competition in this market tightens. Major players are looking to gain momentum in this burgeoning market by increasing their investment in research to launch novel products and diversify their product portfolio.

Key industry developments include:

• August 2019: NuVasive, Inc. commercially launched its Modulus TLIF-A which is a porous titanium spinal implant designed to aid the transforaminal lumbar interbody fusion procedure. This will be the final installment in the company’s Advanced Materials Science product line aimed for all posterior interbody fusion techniques.
• July 2019: Alphatec Spine unveiled its titanium interbody implant system called IdentiTi. The device is engineered for performing anterior lumbar interbody fusion procedures.

The increasing awareness about healthcare importance of proper infrastructure in healthcare set-ups are boosting the global point-of-care diagnostics market, predicts Fortune Business Insights in their new report. The report is titled,” Point-of-care Diagnostics (POC)Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026”.

According to the report, the market is anticipated to reach US$ 28,379.6 Mn by the end of 2026 from US$ 17,019.5 Mn in 2018. The forecast period is set from 2018 to 2026 and the market is expected to grow at a CAGR of 6.6%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

Key players leading the global Point of Care Diagnostics Market include

• Abbott
• Hoffmann-La Roche
• Johnson & Johnson
• BD
• Quidel
• Sekisui Diagnostics, LLC
• Danaher Corporation
• Siemens
• AccuBioTech Co., Ltd.
• Chembio Diagnostic Systems, Inc.
• EKF Diagnostics Holdings plc
• Instrumentation Laboratory (A Werfen Company)
• Nova Biomedical
• PTS Diagnostics

“Increasing Need for Immunotherapy and Other Therapeutic Methods to Promote Growth”

The rise in geriatric population and their vulnerability towards various diseases is a major factor augmenting growth in the global point-of-care diagnostic market. This, coupled with the rising prevalence of infectious diseases is boosting the market. The rise in disposable incomes of people worldwide have encouraged people to opt for better healthcare treatment and facilities. This is further prognosticated to fuel the demand for point-of-care diagnostics market in the coming years.

Furthermore, prevailing occurrences of target diseases is propelling demand for point-of-care treatment methods such as molecular target therapy, immunotherapy, and other therapy methods. Such factors are anticipated to help the market generate better revenues in the years to come.

However, factors such as high cost of installation and high maintenance costs may hamper the market in the long run. Nevertheless, with advancement in technology and new product launches, the market is anticipated to grow remarkably in the years to come.

Increasing digitalization is anticipated to propel growth of the global connected drug delivery devices market. Fortune Business Insights has recently announced a report, titled “Connected Drug Delivery Devices Market Size, Share and Global Trend By Product Type (Sensors, Integrated devices), Application (Diabetes, Multiple Sclerosis, Asthma and COPD, Hypertension), End Users (Home Care Settings, Hospitals, Surgical Centers) and Geography Forecast till 2026” to study various factors influencing the market’s trajectory. The increasing adoption of mobile apps for medical purposes is expected to increase the growth rate in the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380

Some of the Main Key Players Covered in the Report:

• Propeller Health
• Cohero Health Inc.
• AliveCor, Inc.
• Teva Pharmaceutical Industries Ltd.
• Phillips-Medisize, Medtronic
• 3M
• Proteus Digital Health, Inc
• West Pharmaceutical Services, Inc

On the basis of region, in 2018 North America accounted for a considerable share in the global market. The region is expected to keep exhibiting impressive growth through the forecast period 2019-2026. The high presence of key market players, gives North America edge over other regional markets for connected drug delivery. Moreover, technological advancements in drug delivery devices is anticipated to contribute towards market expansion. Europe is projected to emerge as one of the lucrative markets. The region is witnessing high demand for home treatment. Furthermore, favorable reimbursement policies will drive the market in the region.

Technological Advancements in Devices to Aid Market Expansion

Factors expected to drive the global market include advantages of the devices such as reimbursement evidence, better dose measurement, and efficient monitoring of the patient. Moreover, recent innovations in connected drug delivery devices are expected to fuel the demand in the market.

Fortune Business Insights predicts the global diabetes treatment devices market to reach a value of US$ 16,706.4 Mn from US$ 10,826.6 Mn. The forecast period is set from 2018 to 2026, and the market is expected to grow at a CAGR of 5.6%. All information related to the market is provided in the report, titled,”Diabetes Treatment Devices Market Size, Share and Global Trend by Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales (Hospitals, Clinics), Retail Sales (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)) & Geography Forecast till 2026”. The rising prevalence of diabetes on worldwide basis is the main factors propelling growth of the diabetes treatment devices market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetes-treatment-devices-market-100777

According to the report, the insulin pumps segment is expected to register the highest growth rate in the forecast duration. Insulin Pumps are a sub segment of product segmentation of the global diabetes treatment devices market and their highest growth rate is owing to the ease and compatibility of using insulin pumps for people as compared to their other product counterparts.

Rising healthcare Issues Related to Diabetes Encouraging People to Opt for Diabetic Treatment Equipment

As mentioned earlier, the rising prevalence of diabetic people around the world is a major driver for the diabetes treatment device market. This, coupled with advancement in technology and upgradation of existing devices used for diagnosing diabetes is also fueling its demand in the market. The rising healthcare expenditures for diabetes-related issues, especially in developing nations is propelling the demand for using diabetic equipment such as insulin pens and insulin pumps. This is further expected to drive the market in the coming years.

However, the market may face challenges, such as high cost of devices used for treating diabetes which may discourage people from opting these devices. In addition to that, the presence of traditional diabetes treatment methods such as regular allopathic medicines, restricted diet and others may also stop people from adopting the trial and testing methods of controlling diabetes. Furthermore, lack of reimbursement policies, especially in emerging nations may also hamper the market in the long run.